
    
      Eligible participants were randomized to 24 weeks multiple daily injection therapy using
      either the Accu-Chek® Aviva Expert blood glucose meter with an integrated bolus advisor or
      the Accu-Chek® Aviva Nano blood glucose meter and manual bolus calculation.
    
  